JOHNSON & JOHNSON JNJ

expiry = 2023-08-18...chedule TO, which incorporates by reference the information contained in the Exchange Offer, is hereby amended and supplemented by adding the following thereto: (a) Material Terms. The Exchange Offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023. Johnson & Johnson accepted for exchange 190,955,436 shares of J&J Common Stock in exchange for 1,533,830,450 shares of Kenvue Common Stock owned by Johnson & Johnson. Each share of J&J Common Stock accepted for exchange by Johnson & Johns...

must_tender_all = True...portion of the shares of J&J Common Stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Shareholders who owned fewer than 100 shares of J&J Common Stock, or an “odd-lot,” who validly tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares validly tendered by eligible “odd-lot” shareholders have been accepted. The final proration factor of 23.231832% was applied to all other validly tendered shares of J&J Common Stock to determine the number of such shares that were accepted. Base...

threshold = 100...on Stock. Because the Exchange Offer was oversubscribed, Johnson & Johnson accepted only a portion of the shares of J&J Common Stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Shareholders who owned fewer than 100 shares of J&J Common Stock, or an “odd-lot,” who validly tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares validly tendered by eligible “odd-lot” shareholders have been accepted. The final proration factor of 23.231832% was applied to all other validly tendered shares of J...

txn_type = TENDER_OFFERSC TO-I/A 1 jjscto-ia4.htm SC TO-I/A Document SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 4) (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 JOHNSON & JOHNSON (Name of Subject Company (Issuer) and Filing Person (Offeror)) Common Stock, par value $1.00 per share (Title of Class of Securities) 478160104 (CUSIP Number of Class of Securities) Nicholas T. Antoun Johnson & Johnson One Johnson & John...

expired_on = 2023-08-18...chedule TO, which incorporates by reference the information contained in the Exchange Offer, is hereby amended and supplemented by adding the following thereto: (a) Material Terms. The Exchange Offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023. Johnson & Johnson accepted for exchange 190,955,436 shares of J&J Common Stock in exchange for 1,533,830,450 shares of Kenvue Common Stock owned by Johnson & Johnson. Each share of J&J Common Stock accepted for exchange by Johnson & Johnson was exchanged for 8.0324 shares of Ke...

proration_pct = 23.231832...tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares validly tendered by eligible “odd-lot” shareholders have been accepted. The final proration factor of 23.231832% was applied to all other validly tendered shares of J&J Common Stock to determine the number of such shares that were accepted. Based on the final count by the exchange agent, Computershare Trust Company, N.A., the results of the Exchange Offer are as follows: Total number of sh...

tendered = 800449685...epted. Based on the final count by the exchange agent, Computershare Trust Company, N.A., the results of the Exchange Offer are as follows: Total number of shares of J&J Common Stock validly tendered 800,449,685 Shares validly tendered that were subject to proration 793,920,159 “Odd-lot” shares validly tendered that were not subject to proration 6,529,526 Total number of shares of J&J Common Stock accepted 190,955,436 1 On August 23, 2023, Johnson & Johnson issued a press release announcing the final results o...